Your browser doesn't support javascript.
loading
Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors.
Honarvar, Hadis; Westerlund, Kristina; Altai, Mohamed; Sandström, Mattias; Orlova, Anna; Tolmachev, Vladimir; Karlström, Amelie Eriksson.
Afiliação
  • Honarvar H; 1. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Westerlund K; 2. School of Biotechnology, Division of Protein Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Altai M; 1. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Sandström M; 3. Section of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Orlova A; 4. Preclinical PET Platform, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
  • Tolmachev V; 1. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Karlström AE; 2. School of Biotechnology, Division of Protein Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
Theranostics ; 6(1): 93-103, 2016.
Article em En | MEDLINE | ID: mdl-26722376
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article